Cargando…

The clinical impact of gut microbiota in chronic kidney disease

Gut microorganisms play critical roles in both maintaining host homeostasis and the development of diverse diseases. Gut dysbiosis, an alteration of the composition and function of gut microorganisms, is commonly seen in patients with chronic kidney disease (CKD). CKD itself contributes to a disrupt...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, So Mi, Song, Il han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652652/
https://www.ncbi.nlm.nih.gov/pubmed/32872729
http://dx.doi.org/10.3904/kjim.2020.411
_version_ 1783607734783967232
author Kim, So Mi
Song, Il han
author_facet Kim, So Mi
Song, Il han
author_sort Kim, So Mi
collection PubMed
description Gut microorganisms play critical roles in both maintaining host homeostasis and the development of diverse diseases. Gut dysbiosis, an alteration of the composition and function of gut microorganisms, is commonly seen in patients with chronic kidney disease (CKD). CKD itself contributes to a disruption of the symbiotic relationship between the gut microbiota and the host, while the resulting gut dysbiosis may play a part in stage progression of CKD. This bidirectional relationship supports the concept that the gut microbiota is considered a novel focus for the pathogenesis and management of CKD. This article examines the interaction between the gut microbiota and the kidney, the mutual effects of dysbiosis and CKD, and possible treatment options to restore gut eubiosis, and reduce CKD progression and its related complications.
format Online
Article
Text
id pubmed-7652652
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Korean Association of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-76526522020-11-18 The clinical impact of gut microbiota in chronic kidney disease Kim, So Mi Song, Il han Korean J Intern Med Review Gut microorganisms play critical roles in both maintaining host homeostasis and the development of diverse diseases. Gut dysbiosis, an alteration of the composition and function of gut microorganisms, is commonly seen in patients with chronic kidney disease (CKD). CKD itself contributes to a disruption of the symbiotic relationship between the gut microbiota and the host, while the resulting gut dysbiosis may play a part in stage progression of CKD. This bidirectional relationship supports the concept that the gut microbiota is considered a novel focus for the pathogenesis and management of CKD. This article examines the interaction between the gut microbiota and the kidney, the mutual effects of dysbiosis and CKD, and possible treatment options to restore gut eubiosis, and reduce CKD progression and its related complications. The Korean Association of Internal Medicine 2020-11 2020-09-29 /pmc/articles/PMC7652652/ /pubmed/32872729 http://dx.doi.org/10.3904/kjim.2020.411 Text en Copyright © 2020 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Kim, So Mi
Song, Il han
The clinical impact of gut microbiota in chronic kidney disease
title The clinical impact of gut microbiota in chronic kidney disease
title_full The clinical impact of gut microbiota in chronic kidney disease
title_fullStr The clinical impact of gut microbiota in chronic kidney disease
title_full_unstemmed The clinical impact of gut microbiota in chronic kidney disease
title_short The clinical impact of gut microbiota in chronic kidney disease
title_sort clinical impact of gut microbiota in chronic kidney disease
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652652/
https://www.ncbi.nlm.nih.gov/pubmed/32872729
http://dx.doi.org/10.3904/kjim.2020.411
work_keys_str_mv AT kimsomi theclinicalimpactofgutmicrobiotainchronickidneydisease
AT songilhan theclinicalimpactofgutmicrobiotainchronickidneydisease
AT kimsomi clinicalimpactofgutmicrobiotainchronickidneydisease
AT songilhan clinicalimpactofgutmicrobiotainchronickidneydisease